The short version of freeze–thaw cycle fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-10-25 and is reviewed periodically as new material appears.
Several questions remain unresolved. It is not yet known whether the compound reduces cardiovascular events or mortality, because outcome studies require long follow-up. The durability of weight reduction after treatment withdrawal is uncertain, and rebound has been observed with other incretin-based therapies. Long-term safety data covering several years are limited. Effects in adolescents, in pregnancy, and in people with significant kidney or liver impairment have not been characterized in published reports.
Randomized studies of retatrutide measure change in body weight as a percentage of baseline, along with absolute weight loss. Glycemic endpoints include hemoglobin A1c and fasting plasma glucose. Investigators also track blood pressure, lipid fractions, and liver fat content to characterize effects beyond weight alone. Trial designs typically use double-blind, placebo-controlled groups with periodic dose escalation, and they record adverse events throughout both treatment and follow-up periods.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Retatrutide is an investigational synthetic peptide engineered to activate three distinct hormone receptors within a single molecule. It targets the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor simultaneously. This triagonist design distinguishes it from earlier incretin-based compounds that act on one or two of these pathways. Structural modifications relative to native gut hormones extend its residence time in circulation. The molecule remains under clinical evaluation and is not approved for any indication.
| Property | Value | Notes |
|---|---|---|
| Common matrix | Plasma or serum | Collected under controlled conditions |
| Primary method | Liquid chromatography–tandem mass spectrometry | Structural specificity |
| Alternative method | Immunoassay | Lower specificity, higher throughput |
| Reporting unit | ng/mL | Concentration in matrix |
| Key validation item | Selectivity | Interference from related peptides |
Dissolution behavior depends on the amino acid sequence, the counterion content, and the buffer chosen. Many peptides disperse readily in water or mild aqueous buffers, while others require a small amount of organic co-solvent or a change in pH. Adsorption to plastic and glass surfaces can reduce the concentration of a solution over time, particularly at low concentrations. Filtration before analysis removes particulates, and aliquoting limits repeated freeze-thaw cycles that stress the material.
Research-grade peptide material is commonly supplied as a lyophilized powder, a form that limits degradation during transport and storage. Standard practice keeps such material cold and protected from light and moisture, with tighter conditions used for long-term archives. Once dissolved, solutions are generally considered less stable than the dry powder and are handled on shorter timescales. These established conventions derive largely from general peptide chemistry rather than from compound-specific evidence alone.
Identification and purity assessment typically rely on reversed-phase high-performance liquid chromatography, often paired with mass spectrometry. Mass measurement confirms the expected molecular mass and can reveal truncations or modifications. Peptide mapping and sequencing techniques provide sequence-level confirmation when needed. Because related peptide impurities can behave similarly in a single method, orthogonal techniques are usually combined. Reported purity values depend heavily on the method used and should be interpreted with that in mind.
多肽类化合物的表征通常依赖色谱与质谱联用技术。反相高效液相色谱用于评估纯度与有关物质，质谱用于确认分子量，肽图分析通过酶解碎片比对验证一级结构。这些手段组合使用，可以把目标产物与降解产物或类似物区分开来。单一方法往往不足以完成完整确认。
稳定性研究一般关注脱酰胺、氧化与聚集三类降解路径。脱酰胺多发生在天冬酰胺残基上，氧化常涉及甲硫氨酸与色氨酸，聚集则与浓度、温度以及容器界面接触有关。强制降解实验用于识别分子中较敏感的位点。这些结果会直接影响储存条件的设定与有效期的判断。
冻干粉通常在低温环境下保存，复溶之后需要按指定条件在较短时间内使用。反复冻融和剧烈振荡可能促进聚集，低吸附容器则能减少多肽在管壁上的损失。批号、日期与处理条件的完整记录，是后续复核与问题追溯的基础。
Identity and purity are established by instrumental methods rather than by appearance. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and yields a purity value, usually expressed as the share of total peak area. Mass spectrometry checks that the observed mass agrees with the mass calculated from the published sequence, while peptide mapping or amino acid analysis adds structural evidence. Water content, counter-ion identity and residual solvents are sometimes reported as well. A certificate of analysis should name the method behind each figure, because results are method-dependent.
Laboratory handling follows the conventions used for other synthetic peptides. Lyophilized material is weighed and dissolved in an aqueous diluent, typically sterile water or bacteriostatic water, using gentle swirling rather than vigorous shaking, because foaming stresses the chain. Solutions are prepared under clean conditions and, where sterility matters, passed through a suitable filter. Working portions are kept small so that stock material is not repeatedly warmed and cooled, a practice that limits both aggregation and gradual loss of activity.
Pharmacologically, retatrutide acts as a triple agonist at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor. Activation of the first two receptors is associated with improved insulin secretion and reduced appetite. The glucagon receptor component is thought to increase energy expenditure, a mechanism that distinguishes this molecule from dual-agonist compounds. Researchers continue to investigate how the three activities interact and whether the combined profile offers advantages that justify additional clinical testing.
Several questions about the compound remain unresolved. The durability of weight reduction after treatment stops, the frequency of gastrointestinal side effects, and the long-term cardiovascular profile are topics of ongoing study. Regulatory submissions and phase 3 trial outcomes have not been fully reported in the public literature. Because most available data come from controlled trials rather than general-population use, conclusions about effectiveness outside study settings are provisional. The distinction between established findings and open questions matters when interpreting early coverage of the drug.
=== India === In India, Entamoeba is the most common cause of food illness, followed by Campylobacter bacteria, Salmonella bacteria, E. coli bacteria, and norovirus. According to statistics, food poisoning was the second most common cause of infectious disease outbreak in India in 2017. The numbers of outbreaks have increased from 50 in 2008 to 242 in 2017.
In 2008, Freeman was cast in the action-thriller Wanted, a loose adaptation of the comic book miniseries by Mark Millar and J. G. Jones. The plot revolves around Wesley Gibson (James McAvoy), a frustrated account manager who discovers that he is the son of a professional assassin and decides to join the Fraternity, a secret society of which Sloan (Freeman) is the leader. Principal photography took place in Chicago; co-star rapper Common remarked on the set atmosphere: "Freeman is a cool guy. He'd be walking around joking and singing and just dancing. You know, artists are free and I just felt the freedom in him." The film received generally favorable reviews; Peter Howell of Toronto Star thought it was original and one of Freeman's bolder performances to date. Freeman narrated The Love Guru (2008), before appearing in The Dark Knight (2008), the second installment of Christopher Nolan's Dark Knight Trilogy, in which he reprised his role as Lucius Fox. Freeman returned to Broadway in 2008 after an eighteen-year absence to co-star with Frances McDormand and Peter Gallagher in Clifford Odets' play, The Country Girl, directed by Mike Nichols. Freeman continued to accept roles in a diverse range of genres. In 2009, Freeman starred opposite Antonio Banderas in the heist movie Thick as Thieves. Next, he collaborated with Christopher Walken and William H. Macy for the comedy The Maiden Heist. For some time, Freeman expressed a desire to do a film based on Nelson Mandela.
==== TP0453 ==== TP0453 is a 287 amino acid protein associated with the inner membrane of the microbe's outer membrane. This protein lacks the extensive beta sheet structure that is characteristic of other membrane proteins, and does not traverse the outer membrane. This protein's function has been hypothesized to be involved with control of nutrient uptake.
An alternative approach used to measure the relative abundance of radiogenic isotopes when working with a solid surface is secondary-ion mass spectrometry (SIMS). This type of ion-microprobe analysis normally works by focusing a primary (oxygen) ion beam on a sample in order to generate a series of secondary positive ions that can be focused and measured based on their mass/charge ratios. SIMS is a common method used in U-Pb analysis, as the primary ion beam is used to bombard the surface of a single zircon grain in order to yield a secondary beam of Pb ions. The Pb ions are analyzed using a double focusing mass spectrometer that comprises both an electrostatic and magnetic analyzer. This assembly allows the secondary ions to be focused based on their kinetic energy and mass-charge ratio in order to be accurately collected using a series of Faraday cups. A major issue that arises in SIMS analysis is the generation of isobaric interference between sputtered molecular ions and the ions of interest. This issue occurs with U–Pb dating as Pb ions have essentially the same mass as HfO2+. In order to overcome this problem, a sensitive high-resolution ion microprobe (SHRIMP) can be used. A SHRIMP is a double-focusing mass spectrometer that allows for a large spatial separation between different ion masses based on its relatively large size. For U-Pb analysis, the SHRIMP allows for the separation of Pb from other interfering molecular ions, such as HfO2+.
Ancient Iranians were among the first to invent a form of cooler utilizing the principles of evaporative cooling and radiative cooling called yakhchāls. These complexes used subterranean storage spaces, a large thickly insulated above-ground domed structure, and outfitted with badgirs (wind-catchers) and series of qanats (aqueducts). Pre-electric refrigeration In modern times, before the invention of the modern electric refrigerator, icehouses and iceboxes were used to provide cool storage for most of the year. Placed near freshwater lakes or packed with snow and ice during the winter, they were once very common. Natural means are still used to cool foods today. On mountainsides, runoff from melting snow is a convenient way to cool drinks, and during the winter one can keep milk fresh much longer just by keeping it outdoors. The word "refrigeratory" was used at least as early as the 17th century.
Sources: en.wikipedia.org
There was low- to moderate-strength evidence of no benefit for most of the other medications used in RCTs, which included antidepressants (bupropion, mirtazapine, sertraline), antipsychotics (aripiprazole), anticonvulsants (topiramate, baclofen, gabapentin), naltrexone, varenicline, citicoline, ondansetron, prometa, riluzole, atomoxetine, dextroamphetamine, and modafinil.
White sharks communicate with each other through a complex array of body language. Most behaviors have been observed at aggregations around seal rookeries shortly after peak hunting periods, where sharks engage in extensive socializing. At least 20 unique forms of body language are known, most of which consist of two sharks swimming in passing, parallel, or circular patterns to ritualistically examine one another. Occasionally, one shark will openly show off its body in a lateral display to the other. It is hypothesized that the main purpose of these interactions is to establish social rank by size to avoid competition. Observations by Sperone and colleagues in 2010 found display behaviors to be more common between individuals of similar size where differences are not immediately obvious. There is no evidence that sex is a significant factor in behavioral patterns. With dominance established, the smaller shark then acts submissively towards the larger shark by yielding during subsequent encounters or simply avoiding confrontation. Body language is less frequent in California and Australia compared to Dyer Island in South Africa. It is thought that this is because the former locations are less densely populated, and so sharks there are more familiar with each other's hierarchy. Direct violence is extremely rare, as individuals typically end conflicts through peaceful means. Splash fights appear to be the most common way of resolving ownership disputes over prey. Here, one shark slaps the surface with its tail to splash water at the competing shark.
Further shell closures beyond the main island of stability in the vicinity of Z = 112–114 may give rise to additional islands of stability. Although predictions for the location of the next magic numbers vary considerably, two significant islands are thought to exist around heavier doubly magic nuclei; the first near 354126 (with 228 neutrons) and the second near 472164 or 482164 (with 308 or 318 neutrons). Nuclides within these two islands of stability might be especially resistant to spontaneous fission and have alpha decay half-lives measurable in years, thus having comparable stability to elements in the vicinity of flerovium. Other regions of relative stability may also appear with weaker proton shell closures in beta-stable nuclides; such possibilities include regions near 342126 and 462154. Substantially greater electromagnetic repulsion between protons in such heavy nuclei may greatly reduce their stability, and possibly restrict their existence to localized islands in the vicinity of shell effects. This may have the consequence of isolating these islands from the main chart of nuclides, as intermediate nuclides and perhaps elements in a "sea of instability" would rapidly undergo fission and essentially be nonexistent. It is also possible that beyond a region of relative stability around element 126, heavier nuclei would lie beyond a fission threshold given by the liquid drop model and thus undergo fission with very short lifetimes, rendering them essentially nonexistent even in the vicinity of greater magic numbers.
=== The telomerase complex === The full human telomerase complex (the holoenzyme) consists of: one copy each of telomerase RNA (TR or TERC, 452 nucleotides), TERT, and TCAB1, plus two copies of the H/ACA ribonucleoprotein subcomplex. The H/ACA subcomplex consists of two copies each of dyskerin (DKC1), NHP2, NOP10 and GAR1. Each copy of the H/ACA subcomplex binds to a hairpin structure on the telomerase RNA, a feature specific to vertebrates. There is also a histone H2A-H2B dimer wrapping around the telomeric DNA as it operates and its presence is essential for the functioning of the telomerase complex. The presence of TPP1 and POT1 is not detected in the cryo-EM study, but based on previous studies they should be attached to TERT's TEN domain in a way analogous to p50 and Teb1 of Tetrahymena. Previous experiments on catalytically active complex extracted from immortal cells indicated two molecules each of human TERT, telomerase RNA, and dyskerin (DKC1). For comparison, the Tetrahymena telomerase complex consists of: one copy each of TR (TER), TERT, p65 in the core; one copy of p50 (homolog of human TPP1) as the connection to the rest of the structure; one copy each of Teb1 (paralogous to human RPA70), Teb2, and Teb3 (altogether a RPA-like complex); and one copy each of p75, p45, p19 (a CST complex).
2007: Physicist Ibtesam Badhrees was the first Saudi Arabian woman to become a member of the European Organization for Nuclear Research (CERN). 2008: French virologist Françoise Barré-Sinoussi received the Nobel Prize in Physiology or Medicine, shared with Harald zur Hausen and Luc Montagnier, "for their discovery of HIV, human immunodeficiency virus". 2008: American-born Australian Penny Sackett became Australia's first female chief scientist. 2008: American computer scientist Barbara Liskov won the Turing Award for "contributions to practical and theoretical foundations of programming language and system design, especially related to data abstraction, fault tolerance, and distributed computing". 2009: American molecular biologist Carol W. Greider received the Nobel Prize in Physiology or Medicine along with Elizabeth H. Blackburn and Jack W. Szostak "for the discovery of how chromosomes are protected by telomeres and the enzyme telomerase". 2009: After 20 years working on the project, British microscopist Pratibha Gai created the in-situ atomic-resolution environmental transmission electron microscope (ETEM) which allows for visualisation of chemical reactions at the atomic scale. 2009: Israeli crystallographer Ada E. Yonath, along with Venkatraman Ramakrishnan and Thomas A. Steitz, received the Nobel Prize in Chemistry "for studies of the structure and function of the ribosome".
Sources: en.wikipedia.org
Trials measure percentage change in body weight, absolute weight loss, and glycemic markers such as hemoglobin A1c. They also record blood pressure, lipids, and liver fat. Adverse events are tracked throughout.
Mass spectrometry identifies molecules by mass-to-charge transitions, which reduces interference from related peptides. Immunoassays run faster but can cross-react. Structural confirmation usually requires the mass spectrometric approach.
Cardiovascular outcomes, long-term safety, and weight regain after stopping treatment are unresolved. These questions need years of follow-up data. Published evidence covers only limited treatment durations.
It is a synthetic peptide triagonist that engages GIP, GLP-1, and glucagon receptors. Investigational compounds in this class are studied for metabolic conditions rather than for a single organ system.